Among the glycolytic genes, we found the down-regulation of MPC1 (BRP44L), and the up-regulation of HK2 and GPI in prostate cancer, which also showed similar dysregulation patterns in other types of cancers (Supplementary Figure S1). This evidence concerns the gene HK2 and prostate cancer.